Nitric Oxide Involvement in Septic Shock: Do Human Beings behave like Rodents?

[1]  J. Parrillo,et al.  Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. , 1993, The American journal of physiology.

[2]  J. Vincent,et al.  Nitric oxide production is increased in patients after burn injury. , 1996, The Journal of trauma.

[3]  S. Gardiner,et al.  Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats , 1995, British journal of pharmacology.

[4]  P. Vallance,et al.  Induction of NG-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthases? , 1995, The American journal of physiology.

[5]  A. Groeneveld,et al.  Methylene blue increases myocardial function in septic shock. , 1995, Critical care medicine.

[6]  Y. Shiratori,et al.  Increased Nitric Oxide in the Exhaled Air of Patients with Decompensated Liver Cirrhosis , 1995, Annals of Internal Medicine.

[7]  T. Horio,et al.  Increased Nitric Oxide Production in Patients with Hypotension during Hemodialysis , 1995, Annals of Internal Medicine.

[8]  T. Hintze,et al.  Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. , 1995, Circulation.

[9]  R. Cammack,et al.  l‐Arginine depletion by arginase reduces nitric oxide production in endotoxic shock: an electron paramagnetic resonance study , 1995, FEBS letters.

[10]  J. Carcillo,et al.  Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. , 1995, Critical care medicine.

[11]  S. Moncada,et al.  The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. , 1995, Biochemical and biophysical research communications.

[12]  A. Dominiczak,et al.  Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein. , 1995, The American journal of physiology.

[13]  M. Currie,et al.  Regulation of prostaglandin production by nitric oxide; an in vivo analysis , 1995, British journal of pharmacology.

[14]  C. Thiemermann,et al.  Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats , 1995, British journal of pharmacology.

[15]  R. Busse,et al.  Increase in serum NG-hydroxy-L-arginine in rats treated with bacterial lipopolysaccharide. , 1995, European journal of pharmacology.

[16]  J. Vincent,et al.  Methylene blue administration in septic shock: A clinical trial , 1995 .

[17]  M. Hjelm,et al.  L-arginine increases exhaled nitric oxide in normal human subjects. , 1995, Clinical science.

[18]  P. Howdle,et al.  Nitric oxide synthase activity is increased in patients with sepsis syndrome. , 1995, Clinical science.

[19]  S. Moncada,et al.  L-arginine: nitric oxide pathway in endotoxemia and human septic shock. , 1995, Critical care medicine.

[20]  D. Macintyre,et al.  Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin. , 1995, The Journal of pharmacology and experimental therapeutics.

[21]  N. Blau,et al.  Tetrahydrobiopterin as another EDRF in man. , 1994, Biochemical and biophysical research communications.

[22]  C. Mitaka,et al.  Effects of TNF-alpha on hemodynamic changes and circulating endothelium-derived vasoactive factors in dogs. , 1994, The American journal of physiology.

[23]  J. Polak,et al.  Expression of inducible nitric oxide in human lung epithelial cells. , 1994, Biochemical and biophysical research communications.

[24]  M. Ernst,et al.  Nitric oxide synthase: MRNA expression of different isoforms in human monocytes/macrophages , 1994, European journal of immunology.

[25]  G. Tiao,et al.  Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. , 1994, Surgery.

[26]  T. Evans,et al.  Nitric oxide synthesis in patients with advanced HIV infection , 1994, Clinical and experimental immunology.

[27]  T. Billiar,et al.  New insights into the regulation of inducible nitric oxide synthesis. , 1994, The American journal of physiology.

[28]  J. Stamler,et al.  Methylene blue reverses endotoxin-induced hypotension. , 1994, Circulation research.

[29]  S. Moncada,et al.  A rapid and simple method for the measurement of nitrite and nitrate in plasma by high performance capillary electrophoresis. , 1994, Biochemical and biophysical research communications.

[30]  L. Owen-Schaub,et al.  NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs. , 1994, Journal of applied physiology.

[31]  Y. Courtois,et al.  Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. , 1994, Biochemical and biophysical research communications.

[32]  S. Moncada,et al.  Effects of a nitric oxide synthase inhibitor in humans with septic shock. , 1994, Cardiovascular research.

[33]  J. Vincent,et al.  Is endotoxin-induced hypotension related to nitric oxide formation? , 1994, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[34]  D. Beasley,et al.  Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. , 1994, The Journal of experimental medicine.

[35]  J. Pearson,et al.  Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of l‐arginine transport, in activated murine macrophage J774 cells , 1993, British journal of pharmacology.

[36]  W. Hsueh,et al.  Plasma cyclic guanosine monophosphate in chronic heart failure: Hemodynamic and neurohormonal correlations and response to nitrate therapy , 1993, Clinical pharmacology and therapeutics.

[37]  K. Macnaul,et al.  Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. , 1993, Biochemical and biophysical research communications.

[38]  I. Adcock,et al.  Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. , 1993, Biochemical and biophysical research communications.

[39]  V. Laubach,et al.  Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. , 1993, Biochemistry.

[40]  J. Cohen,et al.  Evidence of increased nitric oxide production in patients with the sepsis syndrome. , 1993, Circulatory shock.

[41]  A. Peitzman,et al.  Nitric oxide production is inhibited in trauma patients. , 1993, The Journal of trauma.

[42]  J. Michel,et al.  Vascular relaxation and cyclic guanosine monophosphate in a rat model of high output heart failure. , 1993, Cardiovascular research.

[43]  M. J. Winn,et al.  Effects of NG-substituted arginines on coronary vascular function after endotoxin. , 1993, Journal of applied physiology.

[44]  A. Macleod,et al.  Induction of nitric oxide synthase in human mesangial cells. , 1993, Biochemical and biophysical research communications.

[45]  N. Blau,et al.  Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. , 1993, The Journal of infectious diseases.

[46]  C. Nathan,et al.  Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide , 1993, The Journal of experimental medicine.

[47]  J. Balligand,et al.  Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. , 1993, The Journal of clinical investigation.

[48]  S H Snyder,et al.  Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  I. Fleming,et al.  Influence of endothelium on induction of the L-arginine-nitric oxide pathway in rat aortas. , 1993, The American journal of physiology.

[50]  C. Thiemermann,et al.  Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock , 1993, British journal of pharmacology.

[51]  S. Archer,et al.  Measurement of nitric oxide in biological models , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  S. Tannenbaum,et al.  Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Poole‐Wilson,et al.  Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. , 1992, The American journal of physiology.

[54]  C. Natanson,et al.  N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin , 1992, The Journal of experimental medicine.

[55]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[56]  Å. Wennmalm,et al.  Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin , 1992, British journal of pharmacology.

[57]  D. Herndon,et al.  Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. , 1992, Journal of applied physiology.

[58]  R. Wallace,et al.  Discriminatory effects of protein kinase inhibitors and calcium ionophore on endothelial ICAM-1 induction. , 1992, The American journal of physiology.

[59]  S. Moncada,et al.  Protective and pathological roles of nitric oxide in endotoxin shock. , 1992, Cardiovascular research.

[60]  P. Vallance,et al.  Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock , 1991, The Lancet.

[61]  A. Peitzman,et al.  Nitrogen oxide levels in patients after trauma and during sepsis. , 1991, Annals of surgery.

[62]  N. Cortas,et al.  Pharmacokinetic aspects of inorganic nitrate ingestion in man. , 1991, Pharmacology & toxicology.

[63]  R. L. Simmons,et al.  Modulation of Nitrogen Oxide Synthesis In Vivo: NG‐Monomethyl‐L‐Arginine Inhibits Endotoxin‐Induced Nitrate/Nitrate Biosynthesis While Promoting Hepatic Damage , 1990, Journal of leukocyte biology.

[64]  J. Adams,et al.  Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. , 1990, Biochemical and biophysical research communications.

[65]  J. Parratt,et al.  Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. , 1990, The American journal of physiology.

[66]  C. Thiemermann,et al.  Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. , 1990, European journal of pharmacology.

[67]  K. Gersonde,et al.  Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome. , 1990, Free radical research communications.

[68]  S. Moncada,et al.  EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.

[69]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[70]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[71]  W. Boyce,et al.  Hypertension and Decreased Renal Blood Flow Following Methylene Blue Injection , 1976, Anesthesia and analgesia.

[72]  Carter Vb,et al.  The power of words. , 1951, Lancet.